Videos de Experimentos Relacionados

El interferón alfa para la dermatitis atópica.

R M MacKie

Lancet (London, England)

|May 26, 1990

Resumen

No abstract available in PubMed .

Videos de Conceptos Relacionados

También podría leer

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.

Journal of the National Cancer Institute·2010

Same author

Vitamin D in treated melanoma patients on follow up.

The British journal of dermatology·2009

Same author

Epidemiology of invasive cutaneous melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2009

Same author

Utility of adjuvant systemic therapy in melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2009

Same author

An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0.5 mm thick at diagnosis.

The British journal of dermatology·2008

Same author

Melanoma incidence and mortality in Scotland 1979-2003.

British journal of cancer·2007

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Ver todos los artículos relacionados

Videos de Experimentos Relacionados

El interferón alfa para la dermatitis atópica.

Videos de Conceptos Relacionados

Artículos Relacionados

Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.

Vitamin D in treated melanoma patients on follow up.

Epidemiology of invasive cutaneous melanoma.

Utility of adjuvant systemic therapy in melanoma.

An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0.5 mm thick at diagnosis.

Melanoma incidence and mortality in Scotland 1979-2003.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

El interferón alfa para la dermatitis atópica.

Videos de Conceptos Relacionados

Artículos Relacionados

Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.

Vitamin D in treated melanoma patients on follow up.

Epidemiology of invasive cutaneous melanoma.

Utility of adjuvant systemic therapy in melanoma.

An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0.5 mm thick at diagnosis.

Melanoma incidence and mortality in Scotland 1979-2003.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.